NEXT GENERATION ALZHEIMER’S IMMUNOTHERAPY AND DIAGNOSIS TARGETING NEUROTOXIC AMYLOID BETA OLIGOMERS.

NEXT GENERATION ALZHEIMER’S IMMUNOTHERAPY AND DIAGNOSIS TARGETING NEUROTOXIC AMYLOID BETA OLIGOMERS.

Bibliographic Details
Main Author:	William Klein
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123021978

Similar Items

Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease
by: Yu Ding, et al.
Published: (2019-11-01)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
by: Heinz Hillen
Published: (2023-01-01)

Targeting soluble amyloid-beta oligomers with a novel nanobody
by: Justin R. Haynes, et al.
Published: (2024-07-01)

Beta-sheet structured oligomers of Alzheimer's beta-amyloid peptide perturb phosphatidylcholine model membranes
by: de Planque, M, et al.
Published: (2006)

Inhibition of Alzheimer's disease beta-amyloid aggregation, neurotoxicity and in vivo deposition
by: FERNANDA G. DE FELICE, et al.
Published: (2000-09-01)

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
by: Sheng-Min Wang, et al.
Published: (2024-03-01)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
by: Heeyoung Kang, et al.
Published: (2021-10-01)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
by: Seong Soo A. An, et al.
Published: (2023-01-01)

Halogenation generates effective modulators of amyloid-Beta aggregation and neurotoxicity.
by: H Edward Wong, et al.
Published: (2013-01-01)

Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
by: Wataru Araki, et al.
Published: (2022-01-01)

Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
by: Xiangyuan Meng, et al.
Published: (2024-05-01)

Tau Oligomers Neurotoxicity
by: Grazyna Niewiadomska, et al.
Published: (2021-01-01)

Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
by: Nicholas J Izzo, et al.
Published: (2014-01-01)

THE NEUROTOXIC AMYLOID BETA OLIGOMERS IMPAIR GABAZINE-INDUCED NUCLEAR CA2+ SIGNALS AND THE EXPRESSION OF NEUROPROTECTIVE GENES IN HIPPOCAMPAL NEURONS.
by: Pedro Lobos Zambrano, et al.
Published: (2023-10-01)

AMYLOID BETA OLIGOMERS IMPAIR ENERGY METABOLISM IN OLIGODENDROCYTES
by: Nuria Galbis-Gramage, et al.
Published: (2023-10-01)

SLEEP IS BI-DIRECTIONALLY MODIFIED BY AMYLOID BETA OLIGOMERS
by: Guliz Ozcan, et al.
Published: (2023-10-01)

Sleep is bi-directionally modified by amyloid beta oligomers
by: Güliz Gürel Özcan, et al.
Published: (2020-07-01)

Cyclic adenosine monophosphate-elevating agents inhibit amyloid-beta internalization and neurotoxicity: their action in Alzheimer’s disease prevention
by: Rayudu Gopalakrishna, et al.
Published: (2023-01-01)

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
by: Keun You Kim, et al.
Published: (2022-11-01)

Amyloid-β Oligomers: Multiple Moving Targets
by: Dylan Shea, et al.
Published: (2022-04-01)

Neurotoxicity of Amyloid Beta and its Association with other Biomarkers in Pathogenesis of Alzheimer’s Disease: A Narrative Review
by: Ram Prakash Sah, et al.
Published: (2024-10-01)

Suppression of mature TAU isoforms prevents Alzheimer's disease-like amyloid-beta oligomer-induced spine loss in rodent neurons
by: Sarah Buchholz, et al.
Published: (2024-01-01)

Early onset diagnosis in Alzheimer’s disease patients via amyloid-β oligomers-sensing probe in cerebrospinal fluid
by: Jusung An, et al.
Published: (2024-02-01)

The toxicity of amyloid ß oligomers
by: Zhao, Li Na, et al.
Published: (2013)

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
by: Sylvain E. Lesne
Published: (2014-11-01)

Passive Anti-Amyloid Beta Immunotherapies in Alzheimer’s Disease: From Mechanisms to Therapeutic Impact
by: Thomas Gabriel Schreiner, et al.
Published: (2024-05-01)

Anti-amyloid-beta to tau-based immunization: developments in immunotherapy for Alzheimer's disease
by: Lambracht-Washington D, et al.
Published: (2013-08-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

Nitroxyl Hybrids with Curcumin and Stilbene Scaffolds Display Potent Antioxidant Activity, Remodel the Amyloid Beta Oligomer, and Reverse Amyloid Beta-Induced Cytotoxicity
by: Madhu S. Budamagunta, et al.
Published: (2024-11-01)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
by: Yara Mashal, et al.
Published: (2022-07-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
by: Terrone L. Rosenberry, et al.
Published: (2022-12-01)

Amyloid-β Oligomers Unveil a Novel Primate Model of Sporadic Alzheimer’s Disease
by: Joseph eJebelli, et al.
Published: (2015-03-01)

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
by: Grant A. Krafft, et al.
Published: (2022-04-01)

Breaking the Code of Amyloid-β Oligomers
by: Sylvain E. Lesné
Published: (2013-01-01)

Single Molecule Characterization of Amyloid Oligomers
by: Jie Yang, et al.
Published: (2021-02-01)

Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
by: Haolin Zhang, et al.
Published: (2023-02-01)

Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts
by: Anders Sandberg, et al.
Published: (2022-12-01)

Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
by: Sebastian Jimenez, et al.
Published: (2014-01-01)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
by: Nnana Amakiri, et al.
Published: (2019-05-01)